Coronavirus News Update – June 28: Pfizer-BioNTech and Moderna Vaccines Could Offer Protection for Years, Study Finds

By Anna Breuer on 28 June 2021
  • Share

A coronavirus vaccine syringe

A new study found that the vaccines made by Pfizer-BioNTech and Moderna could offer lasting protection.  The vaccines set off a persistent immune reaction in the body that could last for years, scientists reported in an article in the science journal Nature.

As of Monday morning, the world has recorded over 181.7 million mark in Covid-19 cases and has seen over 3.94 million deaths, according to Worldometer, a service that tracks such information. In addition, 166.2 million people worldwide have recovered from the virus.

In the United States, the death toll, which two weeks ago crossed the 600,000 mark, is now 619,343, an increase of 187 in the past day.  Since the start of the pandemic the country has recorded over 34.5 million individual cases, a higher figure than any other country and one that is followed by India, which now has over 30.3 million officially recorded cases and almost 400,000 officially recorded deaths, although experts now believe that both number are in reality significantly higher.

Since the start of vaccinations at the end of last year over 2.96 billion doses have been administered across the globe as of Monday morning, the equivalent of 39 doses for every 100 people.

The Centers for Disease Control and Prevention said that, as of Monday, 179.3 million people in the United States – or 54% –have received at least one dose of the coronavirus vaccine. Of that population, 46.1%, or 153 million people, are fully vaccinated, and the total number of doses that have been dispensed in the United States is now 323.3 million. Breaking this down further, 66% of the population over the age of 18 – or 170.5 million people – has received at least a first inoculation and 56.8% of the same group – or 146.7 million people – is fully vaccinated.

Oxford researchers reported that a third dose of the Astra Zeneca vaccine that was developed with the University of Oxford generated a strong immune response in clinical trial volunteers. The findings point to using a third shot being used to extend immunity.  Currently, two shots spaced four to 12 weeks apart are used.

Officials in Spain announced they would tighten entry requirements and mandate either proof that an individual is fully vaccinated or proof of a negative Covid test.  The move follows one in the United Kingdom where officials added Spain’s Baleric Islands to its so-called “green list,” which means that British residents returning from the islands do not have to quarantine upon arrival in Britain.

Meanwhile, the India, or Delta, variant of the coronavirus, a strain that appears to be more transmissible and dangerous than others, is likely to break out in a “hyper-regionalize” manner in some parts of the United States, Dr. Scott Gottlieb, the fomer commissioner of the Food and Drug Administration, said on the CBS news program Face the Nation on Sunday.  “There are certain pockets of the country where you are going to have very dense outbreaks,” he said, adding that they will be ones with low vaccination rates and low rates of prior infection.

(Photo: Accura Media Group)

Accura News

Read previous post:
Man Leaps from Moving Plane at LAX After Attempting to Break Into Cockpit

A passenger on a United Airlines flight departing from Los Angeles International Airport was hospitalized Friday night after attempting to...